Genomic aberrations and survival in chronic lymphocytic leukemia

New England Journal of Medicine

Volumn 343, Issue 26 I, 2000, Pages 1910-1916

  Döhner, Hartmut ^a   Stilgenbauer, Stephan ^a   Benner, Axel ^b   Leupolt, Elke ^a   Kröber, Alexander ^a   Bullinger, Lars ^a   Döhner, Konstanze ^a   Bentz, Martin ^a   Lichter, Peter ^b  

^a UNIVERSITY OF ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT PLANNING; TRISOMY 12;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CYTOGENETIC ANALYSIS; DISEASE PROGRESSION; DNA PROBES; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TRISOMY;

EID: 0034727833     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200012283432602     Document Type: Article

References (31)

1. Chronic lymphocytic leukemia
2. Clinical staging of chronic lymphocytic leukemia
3. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
4. Chronic lymphocytic leukemia: Staging and prognostic factors
5. Cytogenetics in chronic lymphocytic leukemia
6. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities
7. Chromosome aberrations in B-cell chronic lymphocytic leukemia: Reassessment based on molecular cytogenetic analysis
8. National Cancer Institute - Sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
9. Comparative genomic hybridization in chronic B-cell leukemias reveals a high incidence of chromosomal gains and losses
10. t(11;14) - Positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemias
11. Incidence and prognostic significance of 6q deletions in B cell chronic lymphocytic leukemia
12. 11q Deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis
13. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma
14. p53 Gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias
15. Fluorescence in situ hybridization of YAC clones after Alu-PCR, amplification
16. Censoring distributions as a measure of follow-up in survival analysis
17. Regression models and life-tables
18. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia
19. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia
20. Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia
21. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival
22. p53 Gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression
23. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukemia
24. ATM mutations in B-cell chronic lymphocytic leukemia
25. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
26. In B-cell chronic lymphocytic leukemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: A cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients
27. Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukemia
28. Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia
29. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
30. H genes are associated with a more aggressive form of chronic lymphocytic leukemia